Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 34, 2022 - Issue 1-2
228
Views
11
CrossRef citations to date
0
Altmetric
Research Articles

Dimensional characteristics of the major types of amphibole mineral particles and the implications for carcinogenic risk assessment

&
Pages 24-38 | Received 18 Oct 2021, Accepted 23 Dec 2021, Published online: 10 Jan 2022

References

  • [ATSDR] Agency for Toxic Substances and Disease Registry. 2001. Toxicological profile for asbestos. US Dept Health and Human Services. https://www.atsdr.cdc.gov/toxprofiles/tp61.pdf.
  • Aust AE, Cook PM, Dodson RF. 2011. Morphological and chemical mechanisms of elongated mineral particle toxicities. J Toxicol Environ Health B Crit Rev. 14(1–4):40–75.
  • Berman DW, Crump KS. 2008a. Update of potency factors for asbestos-related lung cancer and mesothelioma. Crit Rev Toxicol. 38(1):1–47.
  • Berman DW, Crump KS. 2008b. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type. Crit Rev Toxicol. 38(1):49–73.
  • Berman DW, Crump KS, Chatfield EJ, Davis JMG, Jones AD. 1995. The sizes, shapes, and mineralogy of asbestos structures that induce lung tumors or mesothelioma in AF/HAN rats following inhalation. Risk Anal. 15(2):181–195.
  • Fabrigar LR, Wegener DT. 2012. Exploratory factor analysis. Oxford: Oxford University Press.
  • Gamble JF, Gibbs GW. 2008. An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments. Regul Toxicol Pharmacol. 52(1):S154–S186.
  • Garabrant DH, Pastula ST. 2018. A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans. Toxicol Appl Pharmacol. 361:127–136.
  • Gibbs GW, Hwang CY. 1980. Dimensions of airborne asbestos fibres. IARC Sci Publ. 30:69–78. https://europepmc.org/article/med/7239672.
  • Gualtieri A. 2021. Bridging the gap between toxicity and carcinogenicity of mineral fibres by connecting the fibre crystal-chemical and physical parameters to the key characteristics of cancer. Curr Res Toxicol. 2:42–52.
  • Gualtieri AF, Pollastri S, Gandolfi NB, Gualtieri ML. 2018. In vitro acellular dissolution of mineral fibres: a comparative study. Sci Rep. 8(1):7071
  • Hodgson J, Darnton A. 2000. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hygiene. 44(8):565–601. https://pubmed.ncbi.nlm.nih.gov/11108782/.
  • Korchevskiy A, Rasmuson JO, Rasmuson EJ. 2019. Empirical model of mesothelioma potency factors for different mineral fibers based on their chemical composition and dimensionality. Inhal Toxicol. 31(5):189–191.
  • Korchevskiy AA, Wylie AG. 2021. Dimensional determinants for the carcinogenic potency of elongate amphibole particles. Inhal Toxicol. 33(6–8):244–259.
  • Lippmann M. 1988. Asbestos exposure indices. Environ Res. 46(1):86–106.
  • Lippmann M. 2009. Environmental toxicants: human exposures and their health effects. 3rd ed. Hoboken (NJ): John Wiley & Sons, Inc.
  • Loomis D, Dement J, Richardson D, Wolf S. 2010. Asbestos fibre dimensions and lung cancer mortality among workers exposed to chrysotile. Occup Environ Med. 67(9):580–584.
  • McDonald JC, Gibbs GW, Liddell FDK, McDonald AD. 1978. Mortality after long exposure to cummingtonite–grunerite. Am Rev Respir Dis. 118(2):271–277.
  • Mossman BT. 2008. Assessment of the pathogenic potential of asbestiform vs. nonasbestiform particulates (cleavage fragments) in in vitro (cell or organ culture) models and bioassays. Regul Toxicol Pharmacol. 52(1):S200–S203.
  • [NIOSH] National Institute of Occupational Safety and Health. 2016. Current intelligence bulletin 68: NIOSH chemical carcinogen policy. Cincinnati (OH): US Department of Health and Human Services, Centers for Disease Control and Prevention, NIOSH, DHHS Publication No. 2017–100.
  • Oberdörster G. 2002. Toxicokinetics and effects of fibrous and nonfibrous particles. Inhal Toxicol. 14(1):29–56.
  • Oberdörster G, Oberdörster E, Oberdörster J. 2005. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 113(7):823–839.
  • Ono-Ogasawara M, Kohyama N. 1999. Evaluation of surface roughness of fibrous minerals by comparison of BET surface area and calculated one. Ann Occup Hyg. 43(8):505–511.
  • Pooley FD, Clark N. 1979. Fiber dimensions and aspect ratio of crocidolite, chrysotile and amosite particles detected in lung tissue specimens. Ann NY Acad Sci. 330(1):711–716.
  • Pott F. 1978. Some aspects on the dosimetry of the carcinogenic potency of asbestos and other fibrous dusts. Staub-Reinhalt Luft. 38:486–490.
  • Pott F, Ziem U, Reiffer FJ, Huth F, Ernst H, Mohr U. 1987. Carcinogenicity studies on fibres, metal compounds, and some other dusts in rats. Exp Pathol. 32(3):129–152.
  • Shedd KB. 1985. US department of the interior: fiber dimensions of crocidolite from Western Australia, Bolivia, and the Cape and Transvaal Provinces of South Africa. US bureau of mines report of investigations: 8998. Washington (DC): US Department of the Interior. Bureau of Mines. https://jifsan.umd.edu/files/wordpress/wp-content/uploads/2018/11/Asbestos-2018-Ann-Wylie-Ref-2.pdf.
  • Siegrist HG, Wylie AG. 1980. Characterizing and discriminating the shape of asbestos particles. Environ Res. 23(2):348–361.
  • Stanton MF, Layard M, Tegeris A, Miller E, May M, Morgan E, Smith A. 1981. Relation of particle dimension to carcinogenicity in amphibole asbestos and other fibrous minerals. J Natl Cancer Inst. 67(5):965–975.
  • Steenland K, Brown D. 1995. Mortality study of gold miners exposed to silica and nonasbestiform amphibole minerals: an update with 14 more years of follow-up. Am J Ind Med. 27(2):217–229.
  • Timbrell V. 1965. Human exposure to asbestos: dust controls and standards. The inhalation of fibrous dusts. Ann NY Acad Sci. 132(1):255–273.
  • Timbrell V, Ashcroft T, Goldstein B, Heyworth F, Meurman LO, Rendall REG, Reynolds JA, Shilkin KB, Whitaker D. 1988. Relationships between retained amphibole fibres and fibrosis in human lung tissue specimens. Ann Occup Hygiene. 32:323–340.
  • Villeneuve PJ, Mao Y. 1994. Lifetime probability of developing lung cancer, by smoking status, Canada. Can J Public Health. 85(6):385–388.
  • Warnock ML. 1989. Lung asbestos burden in shipyard and construction workers with mesothelioma: comparison with burdens in subjects with asbestosis or lung cancer. Environ Res. 50(1):68–85.
  • Wylie AG, Bailey KF, Kelse JW, Lee RJ. 1993. The importance of width in asbestos fiber carcinogenicity and its implications for public policy. Am Ind Hyg Assoc J. 54(5):239–252.
  • Wylie AG, Korchevskiy A, Segrave A, Duane A. 2020. Modeling mesothelioma risk factors from amphibole fiber dimensionality: mineralogical and epidemiological perspective. J Appl Toxicol. 40(4):515–524.
  • Wylie A, Schweitzer P. 1982. The Effects of sample preparation and measuring techniques on the shape and shape characterization of mineral particles: the case of wollastonite. Environ Res. 27(1):52–73.
  • Wylie AG, Shedd KB, Taylor ME. 1982. Measurement of the thickness of amphibole asbestos fibers with the Scanning Electron Microscope and the Transmission Electron Microscope. Microbeam Analysis Society Electron Microscope Society of America, Proceedings of the Annual Meeting; August; Washington, (DC). p. 181–187.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.